Stellar Biotechnologies Launches New Corporate Website
News May 08, 2014
Stellar Biotechnologies, Inc. has announced the launch of its new corporate website at www.stellarbiotech.com.
Stellar's new website features expanded content in a new format designed to provide customers and investors with the most comprehensive and current information about the Company and its world-leading technology in Keyhole Limpet Hemocyanin (KLH).
The website details Stellar's KLH products, breakthroughs in aquaculture science and strategic expansion of its own immunotherapy program targeting Clostridium difficile ("C. diff") infection.
It also includes a significantly enhanced Investor Relations section intended to streamline access to relevant corporate materials and broaden online exposure for the Company. The Investor Relations pages include up-to-the-minute data, news, corporate presentations, and direct access to historical financial filings.
Mark A. McPartland, Vice President of Corporate Development and Communications of Stellar Biotechnologies, said, "A primary objective for Stellar is presenting key information to stakeholders who are interested in the Company with the most timely and well-organized material. We believe our new website achieves this goal by accurately presenting Stellar's industry-leading KLH technology, products, scientific breakthroughs, expansion of our own immunotherapy program and environmentally sustainable advantage in a user-friendly platform."
Mr. McPartland continued, "A main focal point of the new website is to maximize Stellar's level of corporate transparency for the benefit of investors and we are confident that it succeeds in furthering this transparency. Additionally, the new website allows us to archive an extensive range of corporate materials and information that can be easily accessed by users at their convenience on any Internet-enabled device."
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.